比克替拉韦/恩曲他滨/丙酚替诺福韦 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "比克替拉韦/恩曲他滨/丙酚替诺福韦" in Chinese language version.

refsWebsite

Global rank Chinese rank

9web.archive.org

1^st place

7nih.gov

4^th place

5^th place

2doi.org

2^nd place

23^rd place

1drugs.com

399^th place

208^th place

1hres.ca

low place

1medicines.org.uk

3,823^rd place

3,456^th place

1gileadchina.cn

low place

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Tsiang M, Jones GS, Goldsmith J, Mulato A, Hansen D, Kan E, et al. Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile. Antimicrobial Agents and Chemotherapy. December 2016, 60 (12): 7086–7097. PMC 5118987 . PMID 27645238. doi:10.1128/AAC.01474-16.
Ray AS, Fordyce MW, Hitchcock MJ. Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus. Antiviral Research. January 2016, 125: 63–70. PMID 26640223. doi:10.1016/j.antiviral.2015.11.009 .

drugs.com (Global: 399^th place; Chinese: 208^th place)

Bictegravir / emtricitabine / tenofovir alafenamide (Biktarvy) Use During Pregnancy. Drugs.com. 16 September 2019 [7 March 2020]. （原始内容存档于2020-11-24）.

gileadchina.cn (Global: low place; Chinese: low place)

必妥维®在欧盟获批扩大适应症，用于治疗HIV-1 感染儿童 (PDF). [2024-01-30]. （原始内容存档 (PDF)于2024-04-24）.

hres.ca (Global: low place; Chinese: low place)

hpr-rps.hres.ca

Search Page - Drug and Health Product Register. 23 October 2014 [2024-01-30]. （原始内容存档于2023-01-05）.

medicines.org.uk (Global: 3,823^rd place; Chinese: 3,456^th place)

Biktarvy 50 mg/200 mg/25 mg film-coated tablets - Summary of Product Characteristics (SmPC). (emc). 25 August 2020 [26 August 2020]. （原始内容存档于2021-11-04）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

aidsinfo.nih.gov

FDA-Approved HIV Medicines Understanding HIV/AIDS. AIDSinfo. [2018-05-22]. （原始内容存档于2021-01-27）（美国英语）.
Emtricitabine Dosage, Side Effects. AIDSinfo. [2018-05-22]. （原始内容存档于2020-09-01）（美国英语）.
Tenofovir Alafenamide Information for Providers. AIDSinfo. [2018-05-22]. （原始内容存档于2020-09-02）（美国英语）.

ncbi.nlm.nih.gov

Tsiang M, Jones GS, Goldsmith J, Mulato A, Hansen D, Kan E, et al. Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile. Antimicrobial Agents and Chemotherapy. December 2016, 60 (12): 7086–7097. PMC 5118987 . PMID 27645238. doi:10.1128/AAC.01474-16.
Ray AS, Fordyce MW, Hitchcock MJ. Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus. Antiviral Research. January 2016, 125: 63–70. PMID 26640223. doi:10.1016/j.antiviral.2015.11.009 .

dailymed.nlm.nih.gov

Biktarvy- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate tablet. DailyMed. 8 August 2019 [7 March 2020]. （原始内容存档于2020-08-01）.

pubchem.ncbi.nlm.nih.gov

Emtricitabine. Pubchem. U.S. National Library of Medicine. [2018-05-22]. （原始内容存档于2021-01-12）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Bictegravir / emtricitabine / tenofovir alafenamide (Biktarvy) Use During Pregnancy. Drugs.com. 16 September 2019 [7 March 2020]. （原始内容存档于2020-11-24）.
Search Page - Drug and Health Product Register. 23 October 2014 [2024-01-30]. （原始内容存档于2023-01-05）.
Biktarvy 50 mg/200 mg/25 mg film-coated tablets - Summary of Product Characteristics (SmPC). (emc). 25 August 2020 [26 August 2020]. （原始内容存档于2021-11-04）.
Biktarvy- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate tablet. DailyMed. 8 August 2019 [7 March 2020]. （原始内容存档于2020-08-01）.
FDA-Approved HIV Medicines Understanding HIV/AIDS. AIDSinfo. [2018-05-22]. （原始内容存档于2021-01-27）（美国英语）.
Emtricitabine. Pubchem. U.S. National Library of Medicine. [2018-05-22]. （原始内容存档于2021-01-12）.
Emtricitabine Dosage, Side Effects. AIDSinfo. [2018-05-22]. （原始内容存档于2020-09-01）（美国英语）.
Tenofovir Alafenamide Information for Providers. AIDSinfo. [2018-05-22]. （原始内容存档于2020-09-02）（美国英语）.
必妥维®在欧盟获批扩大适应症，用于治疗HIV-1 感染儿童 (PDF). [2024-01-30]. （原始内容存档 (PDF)于2024-04-24）.